Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
26 05 2020
Historique:
pubmed: 2 4 2020
medline: 3 6 2020
entrez: 2 4 2020
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) is a global pandemic that is wreaking havoc on the health and economy of much of human civilization. Electrophysiologists have been impacted personally and professionally by this global catastrophe. In this joint article from representatives of the Heart Rhythm Society, the American College of Cardiology, and the American Heart Association, we identify the potential risks of exposure to patients, allied healthcare staff, industry representatives, and hospital administrators. We also describe the impact of COVID-19 on cardiac arrhythmias and methods of triage based on acuity and patient comorbidities. We provide guidance for managing invasive and noninvasive electrophysiology procedures, clinic visits, and cardiac device interrogations. In addition, we discuss resource conservation and the role of telemedicine in remote patient care along with management strategies for affected patients.

Identifiants

pubmed: 32228309
doi: 10.1161/CIRCULATIONAHA.120.047063
pmc: PMC7243667
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e823-e831

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

Eur J Pharmacol. 2004 Jan 19;484(1):41-8
pubmed: 14729380
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
BMC Med. 2018 Nov 7;16(1):200
pubmed: 30400791
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Ann Rheum Dis. 2001 Mar;60(3):301
pubmed: 11245140
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Heart Rhythm. 2015 Jul;12(7):e69-100
pubmed: 25981148
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Mayo Clin Proc. 2020 Jun;95(6):1213-1221
pubmed: 32359771
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Cardiothorac Vasc Anesth. 2020 May;34(5):1125-1131
pubmed: 32178954
J Toxicol Clin Toxicol. 1995;33(4):369-70
pubmed: 7629906

Auteurs

Dhanunjaya R Lakkireddy (DR)

The Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, KS (D.R.L., R.G.).

Mina K Chung (MK)

Heart, Vascular, and Thoracic Institute and Lerner Research Institute, Cleveland Clinic, OH (M.K.C.).

Rakesh Gopinathannair (R)

The Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, KS (D.R.L., R.G.).

Kristen K Patton (KK)

University of Washington, Seattle (K.K.P.).

Ty J Gluckman (TJ)

Center for Cardiovascular Analytics, Research and Data Science, Providence Heart Institute, Providence St Joseph Health, Portland, OR (T.J.G.).

Mohit Turagam (M)

Mt Sinai School of Medicine, New York, NY (M.T.).

Jim Cheung (J)

Weill Cornell School of Medicine, New York, NY (J.C.).

Parin Patel (P)

Ascension Health System, Indianapolis, IN (P.P.).

Juan Sotomonte (J)

Centro Cardiovascular, San Juan, PR (J.S.).

Rachel Lampert (R)

Yale School of Medicine, Hartford, CT (R.L.).

Janet K Han (JK)

VA Greater Los Angeles Healthcare System and David Geffen School of Medicine at University of California, Los Angeles (J.K.H.).

Bharath Rajagopalan (B)

Prairie Heart Institute, Springfield, IL (B.R.).

Lee Eckhardt (L)

University of Wisconsin, Madison (L.E., M.L.).

Jose Joglar (J)

University of Texas Southwestern, Dallas (J.J.).

Kristin Sandau (K)

Bethel University, St Paul, MN (K.S.).

Brian Olshansky (B)

Mason City Clinic, IA (B.O.).

Elaine Wan (E)

Columbia University Medical Center, New York, NY (E.W.).

Peter A Noseworthy (PA)

Mayo Clinic, Rochester, MN (P.A.N.).

Miguel Leal (M)

University of Wisconsin, Madison (L.E., M.L.).

Elizabeth Kaufman (E)

Metro Health Medical Center, Cleveland, OH (E.K.).

Alejandra Gutierrez (A)

University of Minnesota School of Medicine, Minneapolis (A.G.).

Joseph E Marine (JE)

Johns Hopkins School of Medicine, Baltimore, MD (J.M.M.).

Paul J Wang (PJ)

Stanford University, Palo Alto, CA (P.J.W.).

Andrea M Russo (AM)

Cooper Medical School of Rowan University, Camden, NJ (A.M.R.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH